The binding of programmed cell death ligand-1 (PD-L1) on RCC tumour cells and programmed cell death-1 (PD-1) on anti-tumour T cells cause downregulation of cytotoxic killing activity and exhaustion of T cells, leading to an immune escape phenomenon. Here, PDCD1 is linked to neoplasm.